Nxera Pharma Achieves Second Milestone in Lilly Diabetes Collaboration

Nxera Pharma Co., Ltd. announces that it has achieved a second development milestone under its multi-target collaboration and license agreement with Eli ...

April 10, 2026 | Friday | News
Novartis Scales Global Community Health Efforts to Tackle Gaps in Chronic Disease Care

Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population health Scales program ...

April 10, 2026 | Friday | News
Emergent BioSolutions Expands Access to NARCAN Nasal Spray with New Carrying Case, Multipacks, and Campus Outreach Initiative

  Emergent BioSolutions Inc. announced a series of initiatives designed to help increase access to NARCAN® Nasal Spray and encourage the pub...

April 09, 2026 | Thursday | News
NexTel Medical Corp Initiates First Phase of Global Rollout for Exosome-Based Cancer Screening Test

NexTel Medical Corp f/k/a Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery syste...

April 09, 2026 | Thursday | News
Mesoblast Limited Secures U.S. Food and Drug Administration IND Clearance for Registrational Trial of Ryoncil in Duchenne Muscular Dystrophy

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients ~15,000 children are living with DMD in the...

April 09, 2026 | Thursday | News
Novonesis Expands Southeast Asia Footprint with Strategic Thailand Facility Acquisition

Novonesis expands global footprint with acquisition of production facility in Southeast Asia Investment of around USD 50 million strengthens ferment...

April 09, 2026 | Thursday | News
SonoNeu Emerges from Stealth to Advance Sonogenetics as a Breakthrough Drug-Free Therapeutic Modality

Sonogenetics, discovered by SonoNeu founder Sreekanth Chalasani, is a new modality using ultrasound to precisely control specific cells ‘tagged&r...

April 08, 2026 | Wednesday | News
Cocrystal Pharma, Inc. Secures FDA Fast Track for CDI-988, Advancing First Oral Antiviral for Norovirus

FDA Fast Track designation supports accelerated development and expedites regulatory review Norovirus is responsible for an estimated 685 million glob...

April 07, 2026 | Tuesday | News
Curanex Pharmaceuticals, Inc. Expands Pipeline to Target Cancer Cachexia, Addressing Major Oncology Supportive-Care Gap

Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Curanex Pharmaceuticals, Inc. (Nasdaq: CURX) (&...

April 07, 2026 | Tuesday | News
Intelligent Bio Solutions Completes Key Clinical Study, Advances Toward FDA 510(k) Clearance for Fingerprint Drug Test

Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for ...

April 07, 2026 | Tuesday | News
BioCardia, Inc. Submits CardiAMP HF Data to FDA, Eyes Accelerated Approval Pathway for Heart Failure Therapy

BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary dis...

April 07, 2026 | Tuesday | News
FDA Extends EYLEA HD Dosing Interval to 20 Weeks, Advancing Long-Term Retinal Care

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with exte...

April 07, 2026 | Tuesday | News
Cipla USA Inc. Secures U.S. FDA Approval for Generic Nintedanib Capsules

- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited announced final approval from the U.S. Food and Drug Administration (USFDA) for its Abbrevi...

April 06, 2026 | Monday | News
OneCyte and Kemp Proteins Partner to Transform Cell Line Development

OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a pioneer in protein engineering and...

April 06, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close